Matthew J. Ellis, MD, PhD, of the Baylor College of Medicine discusses with Harold J. Burstein, MD, PhD, of the Dana-Farber Cancer Institute genome-directed therapeutics for endocrine therapy-resistant estrogen receptor-positive breast cancer.
Gunter von Minckwitz, MD, of the University of Frankfurt, offers his thoughts on abstract S3-04,
Lisa A. Carey, MD, of UNC Lineberger Comprehensive Cancer Center, offers her thoughts on abstract S1-09,
Charles E. Geyer, Jr, MD, FACP, of Massey Cancer Center, discusses abstract S3-08,
Clifford A. Hudis, MD, FACP, of Memorial Sloan Kettering Cancer Center, discusses findings from abstract S3-08,
Hope S. Rugo, MD, of the University of California, San Francisco, discusses abstract S5-08,
Charles E. Geyer, Jr, MD, FACP, on the SOFT Trial
Clifford A. Hudis, MD, FACP, on the SOFT Trial
Hope S. Rugo, MD, on Dietary Intervention as Adjuvant Breast Cancer Therapy
